BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18814309)

  • 1. Modeling and prediction of binding affinities between the human amphiphysin SH3 domain and its peptide ligands using genetic algorithm-Gaussian processes.
    Zhou P; Tian F; Chen X; Shang Z
    Biopolymers; 2008; 90(6):792-802. PubMed ID: 18814309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling and predicting interactions between the human amphiphysin SH3 domains and their peptide ligands based on amino acid information.
    Cai J; Ou R; Xu YS; Yang L; Lin Z; Shu M
    J Pept Sci; 2010 Nov; 16(11):627-32. PubMed ID: 20853307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
    Hou T; Zhang W; Case DA; Wang W
    J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor analysis scales of generalized amino acid information as applied in predicting interactions between the human amphiphysin-1 SH3 domains and their peptide ligands.
    Liang G; Chen G; Niu W; Li Z
    Chem Biol Drug Des; 2008 Apr; 71(4):345-51. PubMed ID: 18318694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
    Hou T; McLaughlin W; Lu B; Chen K; Wang W
    J Proteome Res; 2006 Jan; 5(1):32-43. PubMed ID: 16396493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling and prediction of retention behavior of histidine-containing peptides in immobilized metal-affinity chromatography.
    Tian F; Yang L; Lv F; Zhou P
    J Sep Sci; 2009 Jun; 32(12):2159-69. PubMed ID: 19548218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward quantitative characterization of the binding profile between the human amphiphysin-1 SH3 domain and its peptide ligands.
    He P; Wu W; Wang HD; Yang K; Liao KL; Zhang W
    Amino Acids; 2010 Apr; 38(4):1209-18. PubMed ID: 19669081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico quantitative prediction of peptides binding affinity to human MHC molecule: an intuitive quantitative structure-activity relationship approach.
    Tian F; Yang L; Lv F; Yang Q; Zhou P
    Amino Acids; 2009 Mar; 36(3):535-54. PubMed ID: 18575802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the activity space of peptides binding to diverse SH3 domains using principal property descriptors derived from amino acid rotamers.
    He P; Wu W; Yang K; Jing T; Liao KL; Zhang W; Wang HD; Hua X
    Biopolymers; 2011; 96(3):288-301. PubMed ID: 20690173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaussian process: an alternative approach for QSAM modeling of peptides.
    Zhou P; Chen X; Wu Y; Shang Z
    Amino Acids; 2010 Jan; 38(1):199-212. PubMed ID: 19123053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying chemometrics approaches to model and predict the binding affinities between the human amphiphysin SH3 domain and its peptide ligands.
    Liu L; He D; Yang S; Xu Y
    Protein Pept Lett; 2010 Feb; 17(2):246-53. PubMed ID: 20214647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family.
    Brannetti B; Via A; Cestra G; Cesareni G; Helmer-Citterich M
    J Mol Biol; 2000 Apr; 298(2):313-28. PubMed ID: 10764600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based prediction of the Saccharomyces cerevisiae SH3-ligand interactions.
    Fernandez-Ballester G; Beltrao P; Gonzalez JM; Song YH; Wilmanns M; Valencia A; Serrano L
    J Mol Biol; 2009 May; 388(4):902-16. PubMed ID: 19324052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into human Lck SH3 domain binding specificity: different binding modes of artificial and native ligands.
    Tran T; Hoffmann S; Wiesehan K; Jonas E; Luge C; Aladag A; Willbold D
    Biochemistry; 2005 Nov; 44(45):15042-52. PubMed ID: 16274251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the binding affinity of epitope-peptides with HLA-A*0201 by encoding atom-pair non-covalent interaction information between receptor and ligands.
    Hu L; Ai Z; Liu P; Xiong Q; Min M; Lan C; Wang J; Fan L; Chen D
    Chem Biol Drug Des; 2010 Jun; 75(6):597-606. PubMed ID: 20565476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reexamination of the recognition preference of the specificity pocket of the Abl SH3 domain.
    Santamaria F; Wu Z; Boulègue C; Pál G; Lu W
    J Mol Recognit; 2003; 16(3):131-8. PubMed ID: 12833568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based characterization of the binding of peptide to the human endophilin-1 Src homology 3 domain using position-dependent noncovalent potential analysis.
    Fu C; Wu G; Lv F; Tian F
    J Mol Model; 2012 May; 18(5):2153-61. PubMed ID: 21947444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexibility of interdomain contacts revealed by topological isomers of bivalent consolidated ligands to the dual Src homology domain SH(32) of abelson.
    Xu Q; Zheng J; Xu R; Barany G; Cowburn D
    Biochemistry; 1999 Mar; 38(12):3491-7. PubMed ID: 10090735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of PxxDY motif recognition in SH3 binding.
    Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
    J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.